AMRC

Summary

Our analysis rates AMRC a Sell around current levels. There is no edge to holding a stacked bear trend with elevated beta. For existing holders, we recommend scaling out on strength toward the short-term moving average, with a hard stop above the key moving-average confluence. For new capital, stay flat. Volatility remains high with ATR at 8.4% and implied volatility at 79%, so any short position should be sized qualitatively smaller than normal. Invalidation is a daily close above the short-term average on heavy volume with momentum reclaiming neutral. Downside is toward the recent swing low then the lower Bollinger band. Horizon is 5 trading days; re-evaluate only on a high-volume reclaim of the confluence or a washout capitulation with proof of Q3 receivables collection.

The case

1. Technicals are stacked bearish. Price remains below the 10-day, 50-day, volume-weighted and Bollinger middle averages and sits 23% below the long-term average. Momentum is negative and falling, RSI is not oversold with room to fall, and there is meaningful downside to the lower Bollinger band. Volume confirms distribution with down days well above bounce volume, and the recent higher low off the swing low failed as price stayed below the short-term average with a bearish intraday reversal from open to close.

2. Fundamentals are overwhelmed by cash quality despite operating leverage with revenue +9.1% YoY and operating income +58.4% to 17.7% margin. Cash quality is broken: FCF -$371M TTM and -$240.7M Q2 worst in 5 quarters on $129.8M receivables build to $1.239B, operating cash flow -$107M. Debt $2.02B, D/E 190, net debt $1.82B vs $138M cash, Q2 interest $31.8M >3x net income $9.7M (-24.5% YoY). Funding via dilution: APIC $565M vs $386M YoY, $247M other financing, net debt issuance negative (-$29.6M). Forward PE implies 216% EPS growth to $1.68 not evidenced in cash; P/B is a value trap for a capital-intensive 1.4% net margin name.

3. Sentiment and narrative do not offset. Social sentiment is narrowly bullish on a small sample with 13% explicit breadth, put/call around 0.33 call-heavy at 79% IV is expensive and vulnerable to unwind below the volume-weighted average, $1.5B AI backlog is unverified in filings which flag damages, supply chain and credit facility risks, and the only verified news is Industrials -1.5% vs S&P +10.9% plus a broker downgrade.

4. Risk/reward favors selling. High beta with ATR 8.4% and a cooling market fear gauge amplifies downside risk. There is no prior calibration to contradict the bear view. For holders there is no edge to retaining exposure hoping for a reclaim of the moving-average confluence that volume already rejected; the asymmetric payoff is to the downside with tight invalidation above the short-term average, while new capital should remain flat.

What would weaken it

• High-beta squeeze on high-volume reclaim of MA confluence
• Receivables collection proves cash quality, invalidating thesis
• Volatility expansion (ATR 8.4%, IV 79%) magnifies adverse moves